Selected research
Industry Research
Sleeping Pills (Prescription Drugs) Industry Research Report 2026
Market perspective
The global Sleeping Pills (Prescription Drugs) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sleeping Pills (Prescription Drugs) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sleeping Pills (Prescription Drugs) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sleeping Pills (Prescription Drugs) include Abbott Laboratories, Takeda Pharmaceutical, Sanofi, Hayao, Cayman Chemical, Aurobindo Pharma, Apotex, Ambitropin and Allegiant Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sleeping Pills (Prescription Drugs) market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sleeping Pills (Prescription Drugs) Market by Company
Abbott Laboratories
Takeda Pharmaceutical
Sanofi
Hayao
Cayman Chemical
Aurobindo Pharma
Apotex
Ambitropin
Allegiant Health
Actellon Pharmaceuticals
Sleeping Pills (Prescription Drugs) Segment by Type
Adapin (doxepin)
Ativan (lorazepam)
Ramelteon (Rozerem)
Eszopiclone (Lunesta)
Zolpidem
Sleeping Pills (Prescription Drugs) Segment by Application
Hospital Pharmacy
Retail Pharmacy
Sleeping Pills (Prescription Drugs) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeping Pills (Prescription Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sleeping Pills (Prescription Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeping Pills (Prescription Drugs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sleeping Pills (Prescription Drugs) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adapin (doxepin)
- Ativan (lorazepam)
- Ramelteon (Rozerem)
- Eszopiclone (Lunesta)
- Zolpidem
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- Abbott Laboratories
- Takeda Pharmaceutical
- Sanofi
- Hayao
- Cayman Chemical
- Aurobindo Pharma
- Apotex
- Ambitropin
- Allegiant Health
- Actellon Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sleeping Pills (Prescription Drugs) Market Size (2021-2032)
- 2.2.2 Global Sleeping Pills (Prescription Drugs) Sales (2021-2032)
- 2.2.3 Global Sleeping Pills (Prescription Drugs) Market Average Price (2021-2032)
- 2.3 Sleeping Pills (Prescription Drugs) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Adapin (doxepin)
- 2.3.3 Ativan (lorazepam)
- 2.3.4 Ramelteon (Rozerem)
- 2.3.5 Eszopiclone (Lunesta)
- 2.3.6 Zolpidem
- 2.4 Sleeping Pills (Prescription Drugs) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sleeping Pills (Prescription Drugs) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sleeping Pills (Prescription Drugs) Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Sleeping Pills (Prescription Drugs) Revenue of Manufacturers (2021-2026)
- 3.4 Global Sleeping Pills (Prescription Drugs) Average Price by Manufacturers (2021-2026)
- 3.5 Global Sleeping Pills (Prescription Drugs) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application
- 3.8 Global Manufacturers of Sleeping Pills (Prescription Drugs), Established Date
- 3.9 Global Sleeping Pills (Prescription Drugs) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Takeda Pharmaceutical
- 4.2.1 Takeda Pharmaceutical Company Information
- 4.2.2 Takeda Pharmaceutical Business Overview
- 4.2.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.2.5 Takeda Pharmaceutical Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Hayao
- 4.4.1 Hayao Company Information
- 4.4.2 Hayao Business Overview
- 4.4.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.4.5 Hayao Recent Developments
- 4.5 Cayman Chemical
- 4.5.1 Cayman Chemical Company Information
- 4.5.2 Cayman Chemical Business Overview
- 4.5.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.5.5 Cayman Chemical Recent Developments
- 4.6 Aurobindo Pharma
- 4.6.1 Aurobindo Pharma Company Information
- 4.6.2 Aurobindo Pharma Business Overview
- 4.6.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.6.5 Aurobindo Pharma Recent Developments
- 4.7 Apotex
- 4.7.1 Apotex Company Information
- 4.7.2 Apotex Business Overview
- 4.7.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.7.5 Apotex Recent Developments
- 4.8 Ambitropin
- 4.8.1 Ambitropin Company Information
- 4.8.2 Ambitropin Business Overview
- 4.8.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.8.5 Ambitropin Recent Developments
- 4.9 Allegiant Health
- 4.9.1 Allegiant Health Company Information
- 4.9.2 Allegiant Health Business Overview
- 4.9.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.9.5 Allegiant Health Recent Developments
- 4.10 Actellon Pharmaceuticals
- 4.10.1 Actellon Pharmaceuticals Company Information
- 4.10.2 Actellon Pharmaceuticals Business Overview
- 4.10.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio
- 4.10.5 Actellon Pharmaceuticals Recent Developments
5 Global Sleeping Pills (Prescription Drugs) Market Scenario by Region
- 5.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021-2032
- 5.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021-2026
- 5.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2027-2032
- 5.3 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2021-2032
- 5.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2021-2026
- 5.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2027-2032
- 5.4 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
- 5.4.1 North America Sleeping Pills (Prescription Drugs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
- 5.4.3 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
- 5.5.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
- 5.5.3 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
- 5.7.1 South America Sleeping Pills (Prescription Drugs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
- 5.7.3 South America Sleeping Pills (Prescription Drugs) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2021-2032)
- 6.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2021-2032)
- 6.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2021-2032)
- 6.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2021-2032)
- 6.3 Global Sleeping Pills (Prescription Drugs) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2021-2032)
- 7.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2021-2032)
- 7.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2021-2032)
- 7.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2021-2032)
- 7.3 Global Sleeping Pills (Prescription Drugs) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sleeping Pills (Prescription Drugs) Value Chain Analysis
- 8.1.1 Sleeping Pills (Prescription Drugs) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
- 8.2 Sleeping Pills (Prescription Drugs) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sleeping Pills (Prescription Drugs) Distributors
- 8.2.3 Sleeping Pills (Prescription Drugs) Customers
9 Global Sleeping Pills (Prescription Drugs) Analyzing Market Dynamics
- 9.1 Sleeping Pills (Prescription Drugs) Industry Trends
- 9.2 Sleeping Pills (Prescription Drugs) Industry Drivers
- 9.3 Sleeping Pills (Prescription Drugs) Industry Opportunities and Challenges
- 9.4 Sleeping Pills (Prescription Drugs) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst